Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

NCT01824875 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

144

Enrollment

NETWORK

Sponsor class

Conditions

Gastrinoma
Glucagonoma
Insulinoma
Islet Cell Carcinoma
Pancreatic Polypeptide Tumor
Recurrent Islet Cell Carcinoma
Somatostatinoma

Interventions

DRUG: temozolomide
DRUG: capecitabine

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]